Research ArticleArticle
New Centromere Autoantigens Identified in Systemic Sclerosis Using Centromere Protein Microarrays
Guang Song, Chaojun Hu, Heng Zhu, Li Wang, Fengchun Zhang, Yongzhe Li and Lin Wu
The Journal of Rheumatology February 2013, jrheum.120264; DOI: https://doi.org/10.3899/jrheum.120264
Guang Song
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Chaojun Hu
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Heng Zhu
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Li Wang
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Fengchun Zhang
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Yongzhe Li
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Lin Wu
From the Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China; The Center for High-Throughput Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Graduate University of Chinese Academy of Sciences, Beijing, P.R. China. Supported in part by grants from the Ministry of Science and Technology of the People’s Republic of China (to LW: 2006AA02A311 and 2009CB522204), the National Science Technology Pillar Program in the 11th Five-Year Plan (to YL: 2008BAI59B02 and 2008BAI59B03), the National Natural Science Foundation of China (to YL: 30471617, 30640084, 30872331, and 81072486), and the US National Institutes of Health (to HZ: R44 CA125807, U24 CA160036, U54 RR020839). G. Song, PhD; L. Wu, PhD, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, Graduate University of Chinese Academy of Sciences; C. Hu, MD; L. Wang, MD; F. Zhang, MD, Professor; Y. Li, MD, Professor, Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences; H. Zhu, PhD, Associate Professor, The Center for High-Throughput Biology, Johns Hopkins University School of Medicine. G. Song and C. Hu contributed equally to this work. Address correspondence to Dr. L. Wu, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, People’s Republic of China. E-mail: wul@big.ac.cn, yongzhelipumch@yahoo.com.cn. Accepted for publication December 27, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
New Centromere Autoantigens Identified in Systemic Sclerosis Using Centromere Protein Microarrays
Guang Song, Chaojun Hu, Heng Zhu, Li Wang, Fengchun Zhang, Yongzhe Li, Lin Wu
The Journal of Rheumatology Feb 2013, jrheum.120264; DOI: 10.3899/jrheum.120264